Abstract
Parasites are eukaryotic pathogens and largely include protozoa, helminths and arthropods that cause different diseases to human. Parasitic diseases have a significant impact on developing countries and it has raised the mortality rate to various millions per year. Despite the recent progress, no vaccines are presently available against any of the major parasitic infections of humans. Chemotherapy remains the only option for both clinical and control management. However, conventional drugs are present with features that limit their utility, such as high cost, poor compliance, drug resistance, low efficacy and poor safety. There is thus a clear need for new therapeutic agents against parasites infections.
Keywords: Anti-infective, anti-parasitic, helminths, natural products, parasite, protozoa.
Current Clinical Pharmacology
Title:Editorial (Thematic Issue: Development of Natural Products as Anti-Parasitic Agents)
Volume: 9 Issue: 3
Author(s): Monzote Lianet
Affiliation:
Keywords: Anti-infective, anti-parasitic, helminths, natural products, parasite, protozoa.
Abstract: Parasites are eukaryotic pathogens and largely include protozoa, helminths and arthropods that cause different diseases to human. Parasitic diseases have a significant impact on developing countries and it has raised the mortality rate to various millions per year. Despite the recent progress, no vaccines are presently available against any of the major parasitic infections of humans. Chemotherapy remains the only option for both clinical and control management. However, conventional drugs are present with features that limit their utility, such as high cost, poor compliance, drug resistance, low efficacy and poor safety. There is thus a clear need for new therapeutic agents against parasites infections.
Export Options
About this article
Cite this article as:
Lianet Monzote, Editorial (Thematic Issue: Development of Natural Products as Anti-Parasitic Agents), Current Clinical Pharmacology 2014; 9 (3) . https://dx.doi.org/10.2174/157488470903140806112509
DOI https://dx.doi.org/10.2174/157488470903140806112509 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease
CNS & Neurological Disorders - Drug Targets "Take and Run" and "Take and Hold" Therapeutical Electromagnetic Field Application Modalities in Physiotherapy: Some Clinically Significant Pathways of Action
Current Chemical Biology Arsenic Trioxide in Hematological Malignancies: The New Discovery of an Ancient Drug
Current Pharmaceutical Biotechnology Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Topics in Medicinal Chemistry Treatment of Alzheimer's Disease: Classical Therapeutic Approach
Current Pharmaceutical Analysis Novel Anti-Platelets in Stable Coronary Artery Disease
Current Pharmaceutical Design Guide of Hypertensive Crisis Pharmacotherapy
Cardiovascular & Hematological Disorders-Drug Targets Melatonin Synthetic Analogs as Nitric Oxide Synthase Inhibitors
Mini-Reviews in Medicinal Chemistry Tyrosine Kinase Inhibitors for the Treatment of Rheumatoid Arthritis
Current Topics in Medicinal Chemistry Serotonin Reuptake Inhibition: An Update on Current Research Strategies
Current Medicinal Chemistry Pharmacological Interactions on Blood Pressure Control in Arterial Hypertension, An Issue not to be Overlooked
Cardiovascular & Hematological Disorders-Drug Targets “Micromanaging” Glioblastoma Multiforme: The Potential of MicroRNAs, Circular RNAs, and the Hippo Pathway as Novel Treatment Strategies
Current Neurovascular Research Withdrawal Notice: A Panoramic View on the Phytochemical, Nutritional and Therapeutic value of Ziziphus mauritiana Lam.: A Comprehensive Review
Mini-Reviews in Medicinal Chemistry Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
Current Medicinal Chemistry Advances in Clinical Study of Curcumin
Current Pharmaceutical Design Non-Analgesic Effects of Opioids: Opioids’ Effects on Sleep (Including Sleep Apnea)
Current Pharmaceutical Design Advances in Drug Discovery and Development for Pediatric Tuberculosis
Mini-Reviews in Medicinal Chemistry Effectiveness of Nasal Continuous Positive Airway Pressure (CPAP) Therapy on Cardiovascular Outcomes in Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
Current Respiratory Medicine Reviews The Inflammatory Milieu of the Degenerate Disc: Is Mesenchymal Stem Cell-based Therapy for Intervertebral Disc Repair a Feasible Approach?
Current Stem Cell Research & Therapy Patent Selections
Recent Patents on Biomedical Engineering (Discontinued)